Sammanfattning
Mesenteric traction syndrome (MTS) manifests in 58-87% of patients undergoing upper abdominal surgery and is characterised
by a triad of hypotension, tachycardia, and flushing. Prostacyclin is released from the gut mucosa following intestinal eventration and
cyclooxygenase antagonists prevent the development of MTS. Also the use of remifentanil appears to increase the incidence of MTS
and hypotension is aggravated by epidural analgesia. Yet, prostacyclin may be important for maintaining microcirculation within the
splanchnic area and preserve its mucosal barrier.